Stockreport

Sierra Oncology's momelotinib shows long-term benefit in myelofibrosis [Seeking Alpha]

Sierra Oncology, Inc.  (SRRA) 
Last sierra oncology, inc. earnings: 3/3 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sierraoncology.com
PDF Sierra Oncology (SRRA+7.2%announcesOver periods as long as 10 years, increases in hemoglobin levels were sustained compared to decreases in those receiving Incyte's Jaka [Read more]